About this Journal

The The Journal of Gene Medicine is an international gene therapy journal publishing advances in genetic medicine of relevance to genomics, oncology, neuroscience, virology and pharmacology, incorporating both basic and clinical studies. We welcome papers on DNA and RNA editing, genome editing tools, gene transfer, cell therapy, nanomedicine, and more.

Read the aims and scope  

Articles

Shikonin potentiates skin wound healing in Sprague–Dawley rats by stimulating fibroblast and endothelial cell proliferation and angiogenesis

Graphical Abstract

Description unavailable

Shikonin stimulates the proliferation and migration of fibroblasts and endothelial cells to promote angiogenesis and tissue remodeling and inhibits oxidative stress and inflammatory response, thus accelerating wound healing.

Long non‐coding RNA linc00659 promotes tumour progression by regulating FZD6/Wnt/β‐catenin signalling pathway in colorectal cancer via m6A reader IGF2BP1

Graphical Abstract

Description unavailable

The long non-coding RNA linc00659, which is highly expressed in colorectal cancer, binds to the m6A “reader” insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1). IGF2BP1 promotes the stabilization of FZD6 by recognizing the N6-methyladenosine (m6A) modification site on the FZD6 mRNA, and increased FZD6 activates the Wnt/β-catenin signalling pathway, consequently facilitating the progression of colorectal cancer.

Prognostic evaluation of the novel blueprint of DNA methylation sites by integrating bulk RNA‐sequencing and methylation modification data in endometrial cancer

Graphical Abstract

Description unavailable

This present study constructed predictive models based on patient transcriptome data and DNA methylation data to predict patient clinical outcomes. In the future, by inputting the DNA methylation characteristics of patients, it may be possible to screen suitable clinical strategies for patients.

Multiomics blueprint of PANoptosis in deciphering immune characteristics and prognosis stratification of glioma patients

Graphical Abstract

Description unavailable

In the present study, the four small maps showed step by step that we have constructed a prognostic model that is based on PANoptosis, and demonstrated its significant efficacy in stratifying patients with glioma.

Homologous recombination deficiency reflects the heterogeneity and monitoring treatment response for patients with breast cancer

Graphical Abstract

Description unavailable

  1. Breast cancer was divided into two subtypes that exhibit heterogeneity in prognosis, tumor microenvironment (TME) and tumor mutation burden (TMB) based on the homologous recombination defect (HRD) gene.
  2. A model was constructed by screening six differentially expressed genes between two HRD subtypes.
  3. A six-gene model was a potential predictor for breast cancer prognosis, TMB, immunotherapy and response to antitumor drug therapy.

Reducing the transcriptional read-through rate of a lentiviral vector for β-thalassemia gene therapy

Graphical Abstract

Description unavailable

BB305 is used in clinical trials for treating β-thalassemia. We explored ways to reduce BB305 EATRT based on our previous findings without the cost of reducing its viral preparation titer or erythroid expression efficacy. By using such an approach, we could enhance its biosafety for clinical applications.

Open access

A novel anoikis‐related prognostic signature associated with prognosis and immune infiltration landscape in lung adenocarcinoma

Graphical Abstract

Description unavailable

Based on anoikis-related genes, we developed a risk prediction model to provide individualized and precise treatment for lung adenocarcinoma patients. Patients in different risk groups need to be targeted for treatment.

Bioinformatics analysis of the prognosis and biological significance of N6 methyladenine regulators in oral squamous cell carcinoma

Graphical Abstract

Description unavailable

In the present study, we initiated a comprehensive analysis by downloading The Cancer Genome Atlas-oral squamous cell carcinoma (TCGA-OSCC) datasets to investigate the role of m6A methylation in oral squamous cell carcinoma. Following this, we conducted differentially expressed genes (DEGs) analysis. Simultaneously, principal component analysis (PCA) analysis was employed as a precursor to least absolute shrinkage and selection operator (LASSO) and risk factor analyses, enabling us to uncover potential treatment targets and prognostic indicators. Additionally, receiver operating characteristic (ROC) analysis was executed to identify key regulators, followed by prognostic analysis and molecular docking studies.

Unveiling the immunogenomic landscape of cholangiocarcinoma: Identifying new prognostic markers and therapeutic targets based on CCL5 expression

Graphical Abstract

Description unavailable

The present study provides a comprehensive analysis of the immunogenomic landscape of cholangiocarcinoma (CCA) based on CCL5 expression, revealing significant heterogeneity and contrasting characteristics between different CCA subgroups. A prognostic framework utilizing COX16 and RSAD2 expression profiles was developed and verified.

Pharmacogenomic evaluation of CYP2C19 alleles linking low clopidogrel response and the risk of acute coronary syndrome in Indians

Graphical Abstract

Description unavailable

The efficiency of clopidogrel therapy for acute coronary syndrome (ACS) in Indian patients is influenced by CYP2C19 genetic variations. While *17 allele offers protection, *2 allele carries a high risk. The study provides valuable insights into the distribution and impact of CYP2C19 genetic variants among Indians. The findings suggest that genotyping CYP2C19 alleles in patients undergoing clopidogrel therapy is crucial in understanding the effectiveness and potential risks associated with the medication.

More articles
RESEARCH ARTICLE
Open access

Identifying potential anti‐metastasis drugs for prostate cancer through integrative bioinformatics analysis and compound library screening

  •  14 August 2023

Graphical Abstract

Description unavailable

Copper ions induced prostate cell death. In prostate cancer cells (DU145, PC-3, C4-2B and LNCap), excess copper ions caused abnormal aggregation of thioredoxin in the tricarboxylic acid cycle pathway by directly binding to thioredoxin and interfering with iron–sulfur cluster proteins in the respiratory chain complex, causing a proteotoxic stress response that ultimately leads to cell death.

RESEARCH ARTICLE
Open access

Apoptosis pathways and osteoporosis: An approach to genomic analysis

  •  17 July 2023

Graphical Abstract

Description unavailable

The research identified several genes associated with osteoporosis, such as CASP9, CASP8, CASP3, BAX and TP53. Pathway analysis revealed the involvement of caspase activation through the extrinsic apoptotic signaling pathway. Protein networks and central gene interactions were explored, and the study emphasized the significance of understanding the pathways of osteoporosis apoptosis for predicting susceptibility to the disease.

RESEARCH ARTICLE
Open access

Integrated mRNA and microRNA profiling in lung tissue and blood from human silicosis

  •  4 July 2023

Graphical Abstract

Description unavailable

In the present study, we conducted a comprehensive analysis of differential mRNA and microRNA (miRNA) expression based on silicosis patients and normal people. Many differentially expressed mRNAs and miRNAs between their lung tissues were identified. There was no significant difference for most mRNA or miRNA expression between early stage and advanced stage silicosis lung tissues. In addition, PTEN and GNAI3 expression between lung tissues and blood samples suggested the opposite. PTEN was identified as potential biomarker for silicosis as a result of low methylation in the blood.

RESEARCH ARTICLE

Characterization of neutrophil extracellular traps related gene pair for predicting prognosis in hepatocellular carcinoma

  •  3 July 2023

Graphical Abstract

Description unavailable

The neutrophil extracellular traps (NETs)-related model provides a promising prospect as a prognostic indicator. The nomogram model suggested a favorable classification performance. The immune status of the two risk groups showed a marked difference. Single cell RNA dataset and PCR were performed as validation.

RESEARCH ARTICLE

Antisense lncRNA‐RP11‐498C9.13 promotes bladder cancer progression by enhancing reactive oxygen species‐induced mitophagy

  •  29 June 2023

Graphical Abstract

Description unavailable

Proline is essential for tumor cell metabolism, and pyrroline-5-carboxylate reductase 1 (PYCR1) is a pivotal enzyme for converting P5C to proline. An antisense lncRNA, RP11-498C9.13 increases PYCR1 in bladder cancer by stabilizing the PYCR1 mRNA. PYCR1 promotes the proliferation and invasiveness of bladder cancer cells and enhances reactive species induced-induced mitophagy.

REVIEW ARTICLE
Open access

Gene therapy in cancer

  •  24 June 2023

Graphical Abstract

Description unavailable

Cancer is a heterogeneous and complex disease in which some cells in the body proliferate uncontrollably and invade other tissues and individual differences are quite effective. Treatment using advanced therapy medicinal products, one of which is gene therapy, is gaining importance by the develeopment of biotechnology. Gene therapy strategies in cancer can be classified as antiangiogenic gene therapy, suicide gene therapy, CAR-T cell therapy, immunotherapy, tumor suppressor gene activation and inhibition of oncogene activation.

RESEARCH ARTICLE

Identification of a novel cuproptosis‐related gene signature for rheumatoid arthritis—A prospective study

  •  20 June 2023

Graphical Abstract

Description unavailable

Workflow of this study. First, the expression of RNA modification factors and characteristics of immune infiltration in RA and normal synovial tissues were compared. Then, the prediction model and drug/TF–RNA modification interaction networks were constructed, followed by molecular subtype analysis. Finally, the biomarker was screened.

RESEARCH ARTICLE

B4GALNT1 promotes carcinogenesis by regulating epithelial–mesenchymal transition in hepatocellular carcinoma based on pan‐cancer analysis

  •  20 June 2023

Graphical Abstract

Description unavailable

The proposed working model of B4GALNT1 functions as a tumor carcinogenesis through regulating epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma (HCC) based on pan-cancer analysis. B4GALNT1 promoted the expression of apoptosis-related or EMT-related proteins and then decreased the expression of Bcl-2 and Bcl-xl in HCC cells, suggesting that B4GALNT1 may serve as a promising predictive biomarker and potential therapeutic target for HCC.

RESEARCH ARTICLE

High throughput miRNA sequencing and bioinformatics analysis identify the mesenchymal cell proliferation and apoptosis related miRNAs during fetal mice palate development

  •  15 June 2023

Graphical Abstract

Description unavailable

The results demonstrate clear dynamic microRNA (miRNA) expression during palate development. The mesenchymal cell proliferation and apoptosis related miRNAs and genes are important during development of palate in fetal mice, including mmu-miR-6715-5p-Fgf4, mmu-miR-149-3p-Vegfa, mmu-miR-669m-5p/mmu-miR-466m-5p-Bmp7, mmu-miR-504-3p-Hnf1b, mmu-miR-6912-5p-Pax2, etc.

RESEARCH ARTICLE

Association of matrix metalloproteinase‐2 gene variants with diabetic nephropathy risk

  •  13 June 2023

Graphical Abstract

Description unavailable

The present study included 726 type 2 diabetes (T2D) cases, divided into 222 with nephropathy and 504 cases without nephropathy, and 310 controls. Demographic data and blood samples were taken from participants. DNA was extracted and genotyped for MMP-2, −1306C/T, −790T/G, −1575G/T and −735C/T by a real-time PCR. The −790G allele and GCGC, GTAC haplotypes are associated with a risk of diabetic nephropathy (DN).

More articles
More articles
More articles

Latest news

Recent issues

Skip slideshow